PRPH

PRPH

NASDAQ

ProPhase Labs, Inc.

0.0701

-0.03245(-31.64%)
Volume

0.3M

Market Cap

$0.33M

P/E Ratio

-0.27

EPS

$-27.97


Price Chart

Price Alerts

No price alerts set. Add an alert to get notified!

Notify when price goes above $120.00
Notify when price goes above $180.00
Notify when price goes below $180.00

Key Financial Ratios

P/E Ratio

-0.27

P/B Ratio

1.96

EPS

$-27.97

ROE

-725.74%

Profit Margin

-788.24%

Operating Margin

-570.59%

Peer Comparison

Compare TSM with similar companies in the sector

Company Price Change % P/E Market Cap D/E
ADAP
Adaptimmune Therapeutics plc
$0.05 -3.00% -0.01 $12.53M -0.69
AEMD
Aethlon Medical, Inc.
$2.38 10.19% -0.17 $1.81M 0.06
ALUR
Allurion Technologies Inc.
$0.78 53.32% -1.40 $6.07M -0.40
AYTU
Aytu BioPharma, Inc.
$2.68 1.13% -1.10 $21.71M 1.62
BFRI
Biofrontera Inc.
$0.81 0.32% -0.90 $9.48M 0.59
CODX
Co-Diagnostics, Inc.
$2.21 -2.64% -0.09 $2.48M 0.04
ERNA
Ernexa Therapeutics Inc.
$0.21 -2.36% -0.12 $1.62M 0.20
LNAI
Lunai Bioworks Inc.
$0.37 0.74% -0.07 $6.54M -0.22
SBFM
Sunshine Biopharma, Inc.
$1.02 2.00% -0.79 $5.00M 0.04
TXMD
TherapeuticsMD, Inc.
$2.36 2.97% 90.37 $27.29M 0.24

* Peer stocks are selected based on market capitalization and sector

Private Notes

Key Statistics

52 Week High

$6.70

52 Week Low

$0.07

Dividend

$0.00

Dividend Yield

0.00%

About ProPhase Labs, Inc.

ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. The company also provides contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; SARS-CoV-2 (COVID-19) and COVID-19 viral mutation polymerase chain reaction tests through saliva and nasal swab methods; and other respiratory pathogen panel molecular testing services, as well as personal genomics products and services. It serves national chain drug, internet-based, and various regional retailers. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.